Geode Capital Management LLC raised its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 10.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 135,959 shares of the company's stock after buying an additional 12,964 shares during the quarter. Geode Capital Management LLC owned about 1.87% of Semler Scientific worth $3,202,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in the stock. Newbridge Financial Services Group Inc. bought a new position in Semler Scientific during the second quarter valued at approximately $34,000. Quest Partners LLC bought a new position in shares of Semler Scientific during the 2nd quarter valued at approximately $59,000. Meeder Asset Management Inc. purchased a new position in shares of Semler Scientific in the second quarter valued at $67,000. US Bancorp DE increased its position in Semler Scientific by 60.8% in the third quarter. US Bancorp DE now owns 3,064 shares of the company's stock worth $72,000 after purchasing an additional 1,158 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Semler Scientific by 27.1% during the second quarter. Rhumbline Advisers now owns 6,197 shares of the company's stock valued at $213,000 after purchasing an additional 1,320 shares in the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.
Semler Scientific Stock Performance
SMLR stock traded down $3.70 during trading on Tuesday, hitting $55.24. 366,160 shares of the company's stock traded hands, compared to its average volume of 419,413. Semler Scientific, Inc. has a 52 week low of $20.88 and a 52 week high of $81.56. The stock has a market capitalization of $511.91 million, a price-to-earnings ratio of 26.95 and a beta of 1.18. The business has a fifty day simple moving average of $55.94 and a 200 day simple moving average of $38.21.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, beating analysts' consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million during the quarter.
Semler Scientific Profile
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.